Global Medical Affairs Strategy Leader Oncology

Vice President, Head of Global Medical Affairs Strategy Join to apply for the Vice President, Head of Global Medical Affairs Strategy role at Revolution Medicines Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The companys R&D pipeline...

Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our...

Vice President, Head of Global Medical Affairs Strategy Join to apply for the Vice President, Head of Global Medical Affairs Strategy role at Revolution Medicines Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D...

Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product...

Overview Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on...

Use Your Power for Purpose At Pfizer, our mission is to cultivate a best-in-class culture of continuous improvement and project management that empowers colleagues and streamlines effective processes. Whether you are managing projects or collaborating with others, your role in this team is crucial in making our work more efficient and faster. This enables us...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product...

Join Us in Transforming Healthcare At Pfizer, our mission focuses on creating a dynamic culture of project management and continuous improvement that empowers our colleagues and enhances processes. As a member of our team, your role is vital in driving efficiency, enabling us to deliver innovative breakthroughs that change the lives of patients globally....